دورية أكاديمية
Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers
| العنوان: | Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers |
|---|---|
| المؤلفون: | Petakh, PavloAff1, Aff2, IDs10787023013417_cor1, Kamyshna, Iryna, Kamyshnyi, AleksandrAff2, IDs10787023013417_cor3 |
| المصدر: | Inflammopharmacology: Experimental and Therapeutic Studies. 32(1):885-891 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 09254692 15685608 |
|---|---|
| DOI: | 10.1007/s10787-023-01341-7 |